Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa Lessa Benedet, Alyssa Stevensson, Natàlia Vilor‐Tejedor et al.|JAMA Neurology|2021Cited by 627
Synaptic Changes in Parkinson Disease Assessed with in vivo ImagingDavid Matuskey, Richard E. Carson, Sjoerd J. Finnema et al.|Annals of Neurology|2020Cited by 186
Imaging Neuroinflammation in Gray and White Matter in Schizophrenia: An In-Vivo PET Study With [18F]-FEPPAMiran Kenk, Romina Mizrahi, Thiviya Selvanathan et al.|Schizophrenia Bulletin|2014Cited by 168
Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [<sup>18</sup>F]FEPPASina Hafizi, Romina Mizrahi, Huai‐Hsuan Tseng et al.|American Journal of Psychiatry|2016Cited by 122
Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [18F]-FEPPAIvonne Suridjan, Romina Mizrahi, Pablo Rusjan et al.|NeuroImage|2013Cited by 69